Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Matthew Cooper who wrote (14313)	5/4/1998 11:32:00 PM
From: E	Read Replies (2) \| Respond to of 34592

The New York Times said that when only one of the two chemicals was used, it was a treatment-- that is, it shrunk tumors as long as it was taken. When the two chemicals were used together, all traces of cancer disappeared, not to return even after the drug combo was discontinued, and that was called a cure. It would seem that for mice, they do have a "cure." Would it be possible for you to explain (in simple terms) why a compound that would cut off the blood supply to a tumor (in fact to any cancer, including leukemia) in a mouse might not do the same in a human being?